PSMA5 and prostate cancer: In this study, we evaluated the characteristics of a novel 211At-labeled PSMA compound ([211At]PSMA5) and its therapeutic effect in a mouse xenograft model of prostate cancer and compared it with two closely related new derivatives, namely [211At]PSMA1 and [211At]PSMA6.